Back to Search Start Over

Driving performance and neurocognitive skills of long-term users of benzodiazepine anxiolytics and hypnotics

Authors :
van der Sluiszen, Nick N.J.J.M.
Vermeeren, Annemiek
Verster, Joris C.
van de Loo, Aurora J.A.E.
van Dijken, Joke H.
Veldstra, Janet L.
Brookhuis, Karel A.
de Waard, Dick
Ramaekers, Johannes G.
Afd Pharmacology
One Health Toxicologie
dIRAS RA-1
Pharmacology
Section Psychopharmacology
RS: FPN NPPP II
Afd Pharmacology
One Health Toxicologie
dIRAS RA-1
Pharmacology
Clinical Neuropsychology
Source :
Human Psychopharmacology-Clinical and Experimental, 34(6):e2715. Wiley, Human Psychopharmacology, Human Psychopharmacology, 34(6):e2715. John Wiley and Sons Ltd, Human Psychopharmacology, 34(6). John Wiley and Sons Ltd
Publication Year :
2019

Abstract

OBJECTIVE: The aim of this study is to compare actual driving performance and skills related to driving of patients using benzodiazepine anxiolytics or hypnotics for at least 6 months to that of healthy controls.METHODS: Participants were 44 long-term users of benzodiazepine and benzodiazepine-related anxiolytics (n = 12) and hypnotics (n = 32) and 65 matched healthy controls. Performance was assessed using an on-the-road driving test measuring standard deviation of lateral position (SDLP, in cm) and a battery of neurocognitive tasks. Performance differences between groups were compared with a blood alcohol concentration of 0.5 mg/ml to determine clinical relevance.RESULTS: Compared with controls, SDLP was significantly increased in hypnotic users (+1.70 cm) but not in anxiolytic users (+1.48 cm). Anxiolytic and hypnotic users showed significant and clinically relevant impairment on neurocognitive task measuring executive functioning, vigilance, and reaction time. For patients using hypnotics for at least 3 years, no significant driving impairment was observed.CONCLUSION: Impairing effects of benzodiazepine hypnotics on driving performance may mitigate over time following longer term use (i.e. 3 years or more) although neurocognitive impairments may remain.

Details

Language :
English
ISSN :
08856222
Database :
OpenAIRE
Journal :
Human Psychopharmacology-Clinical and Experimental, 34(6):e2715. Wiley, Human Psychopharmacology, Human Psychopharmacology, 34(6):e2715. John Wiley and Sons Ltd, Human Psychopharmacology, 34(6). John Wiley and Sons Ltd
Accession number :
edsair.doi.dedup.....6c7e6b55cccdf61946a112469890e8c6